Avanos Medical
AVNS • NYSE
Avanos Medical is a medical - devices company in the healthcare sector trading on NYSE, led by CEO David C. Pacitti, with a market cap of $628.8M.
CEODavid C. Pacitti
Next Earnings
Upcoming earnings announcement for Avanos Medical
Date
Tuesday, May 5, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.18
Revenue Estimate
$169.7M
Earnings History
Past 12 earnings reports for Avanos Medical
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | Q4 2025 | $0.29Est: $0.25 | +16.0% | $180.9MEst: $175.3M | +3.2% |  10-K |
| Nov 5, 2025 | Q3 2025 | $0.22Est: $0.15 | +46.7% | $177.8MEst: $165.2M | +7.6% | 10-Q |
| Aug 5, 2025 | Q2 2025 | $0.17Est: $0.16 | +6.3% | $175.0MEst: $166.2M | +5.3% | 10-Q |
| May 6, 2025 | Q1 2025 | $0.26Est: $0.18 | +44.4% | $167.5MEst: $161.8M | +3.6% | 10-Q |
| Feb 26, 2025 | Q4 2024 | $0.43Est: $0.40 | +7.5% | $179.6MEst: $177.2M | +1.3% | 10-K |
| Oct 30, 2024 | Q3 2024 | $0.36Est: $0.35 | +2.9% | $170.4MEst: $175.3M | -2.8% | 10-Q |
| Jul 31, 2024 | Q2 2024 | $0.34Est: $0.29 | +17.2% | $171.7MEst: $170.7M | +0.6% | 10-Q |
| May 2, 2024 | Q1 2024 | $0.19Est: $0.21 | -9.5% | $166.1MEst: $162.9M | +2.0% | 10-Q |
| Feb 20, 2024 | Q4 2023 | $0.36Est: $0.37 | -2.7% | $173.3MEst: $170.4M | +1.7% | 10-K |
| Nov 1, 2023 | Q3 2023 | $0.30Est: $0.28 | +7.1% | $171.3MEst: $169.6M | +1.0% | — |
| Aug 9, 2023 | Q2 2023 | $0.24Est: $0.30 | -20.0% | $169.4MEst: $186.2M | -9.0% | 10-Q |
| May 3, 2023 | Q1 2023 | $0.27Est: $0.27 | 0.0% | $191.7MEst: $195.2M | -1.8% | — |